Developing electronic-nose technologies for clinical practiceAuthor(s): Alphus Dan Wilson
Source: Journal of Medical & Surgical Pathology
Publication Series: Scientific Journal (JRNL)
Station: Southern Research Station
Download Publication (746.0 KB)
The development of relatively simple gas-sensing devices with sensor arrays capable of constructing molecular profiles of complex Volatile Organic Compound (VOC) metabolites from clinical samples, based on production of healthy or disease-specific digital signature patterns, may soon help to revolutionize diagnostic procedures in clinical practice. This mini-review summarizes the development of recent portable electronic-nose (e-nose) technologies as new diagnostic tools with the potential for accelerating clinical procedures to facilitate non-invasive early disease diagnoses, improving the speed and accuracy of Point-Of-Care Testing (POCT); yielding more effective treatments and significantly improving prognoses.
- You may send email to email@example.com to request a hard copy of this publication.
- (Please specify exactly which publication you are requesting and your mailing address.)
- We recommend that you also print this page and attach it to the printout of the article, to retain the full citation information.
- This article was written and prepared by U.S. Government employees on official time, and is therefore in the public domain.
CitationWilson, A. D. 2018. Developing electronic-nose technologies for clinical practice. Journal of Medical & Surgical Pathology 3(4): 169.
KeywordsEarly non-invasive disease detection, Disease biomarker signatures, E-nose VOC profiles
- Application of electronic-nose technologies and VOC-biomarkers for the noninvasive early diagnosis of gastrointestinal diseases
- Electronic-nose devices - Potential for noninvasive early disease-detection applications
- Applications of electronic-nose technologies for noninvasive early detection of plant, animal and human diseases
XML: View XML